Fluticasone Propionate Chemical Structure (Floventhfa Spl Graphic 01)
Flovent
Product Images NDC 50090-0916
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Flovent (NDC 50090-0916). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Floventhfa Spl Graphic 02)
This appears to be a report of a clinical trial or study involving a medication called "FLOVENT HFA 88 mcg" administered twice daily to individuals (group referred to as "Placebo"). The study appears to have evaluated the change in "FEV" (which likely stands for forced expiratory volume) from a baseline measurement at various time points (all labeled with the letter "T") up to an endpoint labeled "12". The rest of the text does not appear to provide any additional useful information about the study.*
Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Floventhfa Spl Graphic 03)
This appears to be a chart or graph showing the change from baseline in FEV (forced expiratory volume) for various treatments, including a placebo and different doses of FLOVENT HFA. The chart shows the percentage of change at different endpoints measured over a period of 12 weeks.*
Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Floventhfa Spl Graphic 04)
The text represents a graph showing the percentage of subjects with an increase or reduction in dose of FLOVENT HFA medication. The graph displays the percentage of subjects on the Y-axis ranging from 0% to 60% and the different dose levels on the X-axis. The percentage of subjects is shown for Placebo, FLOVENT HFA 440mcg twice daily, and FLOVENT HFA 880 mcg twice daily.*
Figure A (Floventhfa Spl Graphic 05)
The text describes a metal canister with a dark orange plastic actuator and mouthpiece. It also has a counter peach cap.*
Figure B (Floventhfa Spl Graphic 06)
Fgure C (Floventhfa Spl Graphic 07)
Figure D (Floventhfa Spl Graphic 08)
Figure E (Floventhfa Spl Graphic 09)
The text refers to the attributes of a mouthpiece, including its position (down), color (dark orange), and the fact that it is a mouthpiece. The context and purpose of the mouthpiece is not given, so no further information can be determined.*
Figure F (Floventhfa Spl Graphic 10)
This is a simple instruction that tells the reader to exhale or breathe out as much air as they can. It is likely a part of a breathing technique or exercise designed to improve lung capacity or relaxation.*
Figure G (Floventhfa Spl Graphic 11)
Figure H (Floventhfa Spl Graphic 12)
Figure I (Floventhfa Spl Graphic 13)
Floventhfa Spl Graphic 14
Label Image (Lbl500900916)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
